Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

485results about How to "Improve kidney function" patented technology

Systemic insulin-like growth factor-1 therapy reduces diabetic peripheral neuropathy and improves renal function in diabetic nephropathy

InactiveUS20100216709A1Prevents subsequent hyposensitivityEasy maintenanceOrganic active ingredientsNervous disorderInsulin-like growth factorHyperglycemic disorder
The present invention provides methods of treatment of patients suffering from the complications of blood sugar disorders: diabetic peripheral neuropathy and diabetic nephropathy by administration of IGF-1 via protein therapy or gene therapy. It relates to methods of treating an individual having a diabetic disorder or a hyperglycemic disorder, comprising administering to the individual an effective amount of a DNA vector expressing IGF-1Eb or IGF-1Ec in vivo or an effective amount of at the IGF-1Eb or IGF-1Ec protein in the early hyperalgesia stage or in patients that have advanced to the hyposensitivity stage. Treatment at the early hyperalgesia stage prevents subsequent hyposensitivity with increases or maintenance of sensory nerve function. IGF-1Eb or IGF-1Ec treatment also increases muscle mass and improves overall mobility, which indicates a treatment-related improvement in motor function. Treatment with IGF-1Eb or IGF-1Ec at the hyposensitivity stage reverses hyposensitivity and improves muscle mass and overall health. Systemic IGF-1 provides a therapeutic modality for treating hyposensitivity associated with DPN. In addition, IGF-1Eb or IGF-1Ec provides a therapeutic modality for treating diabetic nephropathy. IGF-1Eb or IGF-1Ec improves renal function as evidenced by a modulation in serum albumin concentration and a reduction in urine volume and protein levels. IGF-1Eb or IGF-1Ec also reduces diabetic glomerulosclerosis.
Owner:GENZYME CORP

Weight reducing and fat reducing special type clinic nutrition recipe and preparation method thereof

InactiveCN107319525APrevent Fat DegenerationHas the effect of reducing fatFood ingredient functionsNutrition supportDietary fiber
The invention relates to a weight reducing and fat reducing special type clinic nutrition recipe, which comprises 20 to 38 parts of protein, 8 to 12 parts of fat, 40 to 50 parts of carbohydrate, 5 to 8 parts of dietary fiber, 0.3 to 1.5 parts of macro elements, 0.01 to 0.04 part of trace elements, 0.005 to 0.015 part of lipid-soluble vitamin, 0.01 to 0.3 part of water-soluble vitamin, 0.05 to 1 part of dietary essence, 0.1 to 2 parts of medical and edible ingredients, 0.1 to 3 parts of natural plant compounds and 0.005 to 2 parts of new resource food, wherein the medical and edible ingredients are selected from at least one of poria cocos, fructus lycii, lotus leaves, semen cassiae, radix platycodi, rhizoma dioscoreae, fructus crataegi and coix seeds; each ingredient is prepared into powder in advance; the fat and the vitamin are prepared into powder by using a micro-capsule embedding technology. Through the screening and the proportioning of the ingredients, the nutrition recipe provides reasonable and overall nutrition support for patients with adiposity; meanwhile, the medical and edible ingredients, the natural plant compounds and the new resource food with the effects of replenishing qi to invigorate the spleen, eliminating phlegm, removing dampness and reducing weight and fat are added, so that the effects of preventing and treating the adiposity are achieved.
Owner:SHANGHAI FUDAN AOYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products